Golden State Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Golden State Wealth Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$41.3K	Sell	456 -70	-13%	-$6.42K	﹤0.01%	729
2025 Q4	$47.4K	Buy	526 +1	+0.2%	+$95	0.01%	705
2025 Q3	$51.8K	Sell	525 -49	-9%	-$4.86K	0.01%	668
2025 Q2	$52.4K	Sell	574 -103	-15%	-$9.96K	0.01%	630
2025 Q1	$76.6K	Sell	677 -18	-3%	-$1.93K	0.01%	509
2024 Q4	$73.5K	Buy	+695	New	+$74.6K	0.01%	492
2020 Q2	–	Sell	-362	Closed	-$35K	–	953
2020 Q1	$35K	Buy	+362	New	+$47.5K	0.02%	416
2019 Q4	–	Sell	-362	Closed	-$48K	–	1005
2019 Q3	$48K	Buy	362 +1	+0.3%	+$129	0.02%	439
2019 Q2	$41K	Sell	361 -1	-0.3%	-$117	0.01%	498
2019 Q1	$45K	Buy	+362	New	+$41.1K	0.02%	474

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Golden State Wealth Management's ZBH Position: Q1 2026 in Review

Golden State Wealth Management reduced its Zimmer Biomet (ZBH) stake by 13% in Q1 2026, selling an estimated $6.42K and leaving 456 shares worth $41.3K. The position accounts for ﹤0.01% of the portfolio, ranked #729.

Golden State Wealth Management first reported a position in ZBH in Q1 2019 and has held it in 10 quarters since. The position peaked at $76.6K in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Golden State Wealth Management held 456 shares of Zimmer Biomet worth $41.3K as of Q1 2026.
Golden State Wealth Management sold 70 Zimmer Biomet shares in Q1 2026, an estimated $6.42K.
Zimmer Biomet made up ﹤0.01% of Golden State Wealth Management's portfolio in Q1 2026, its #729 holding.
Golden State Wealth Management first reported a position in Zimmer Biomet in Q1 2019 and has held it in 10 quarters since.
Golden State Wealth Management's Zimmer Biomet position peaked at $76.6K in Q1 2025.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Golden State Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.